Evaluation of the effectiveness of functional rehabilitation in patients with multiple sclerosis
DOI:
https://doi.org/10.12775/JEHS.2022.12.09.030Keywords
functional rehabilitation, multiple sclerosis, neurological diseaseAbstract
Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system. May have individual and dynamic course, with symptoms of varying severity. It takes 4 forms: relapsing-remitting, primary progressive, secondary progressive and relapsing-chronic.
Aim of the research: Evaluation of the effectiveness of functional rehabilitation
in patients suffering from multiple sclerosis.
Material and methods: The research group consisted of 94 people (67 women and 27 men) aged 24-70 years, diagnosed with multiple sclerosis. Study participants went through a four-week process rehabilitation based on functional exercise. In research the survey method was used and the research technique was used proprietary questionnaire.
Results: The research confirmed the improvement of physical fitness of patients suffering from multiple sclerosis due to the rehabilitation process. In total, 78.72% of the respondents described their physical condition as better or much better than before rehabilitation. Only
a few – 3,19% – considered that rehabilitation did not improve the quality of life. The vast majority of respondents - 70.21% as a result of rehabilitation indicated an improvement
in independence in everyday functioning. In 93,62% it influenced a better well-being.
Conclusions: A correlation has been demonstrated between the performance
of kinesiotherapeutic rehabilitation in patients with multiple sclerosis and the improvement
of their physical fitness. A significant difference was found in the degree of satisfaction with one’s own functional state before and after the rehabilitation process.
References
Losy J., Bartosik-Psujek H., Członkowska A. Leczenie stwardnienia rozsianego. Zalecenia Polskiego Towarzystwa Neurologicznego. Polski Przegląd Neurologiczny, 2016;12(2):80-95.
Kamińska J., Koper M., Piechal K. Stwardnienie rozsiane – etiopatogeneza
i możliwości diagnostyczne. Postepy Hig Med Dosw, 2017; 71: 551-563.
Rosiak K., Zagożdżon P. Czynniki środowiskowe w epidemiologii stwardnienia rozsianego. Probl Hig Epidemiol 201; 93(4): 627-631.
Dymecka J., Gerymski R. Niepełnosprawność a jakość życia pacjentów
ze stwardnieniem rozsianym. Mediacyjna rola zapotrzebowania na wsparcie społeczne. CSN 2019; 4(46): 63-78.
Fyda W., Kozioł S., Hładki W. Ocena skuteczności postępowania fizjoterapeutycznego u osób chorych na stwardnienie rozsiane. Ostry Dyżur 2017; 10(3); 84-89.
Potemkowski A. Zespół kliniczny izolowany a stwardnienie rozsiane – podstawy komunikacji z pacjentem. Polski Przegląd Neurologiczny 2015; 11(1); 1-6.
Doshi A., Chataway J. Multiple sclerosis, a treatable disease. Clinical Medicine 2016; 16(6); 53-59.
Brola W., Kasprzyk M., Fudala M. Opieka paliatywna nad pacjentem ze stwardnieniem rozsianym. Medycyna Paliatywna 2013; 5(2); 41-47.
Garczyński W., Krajewski S. Próba ukierunkowania rehabilitacji u pacjentów
ze stwardnieniem rozsianym w zależności od typu klinicznego choroby. Journal
of Education, Health and Sport 2016; 6(7); 35-58.
Hojsgaard Chow H., Schreiber K., Magyair M. Progressive multiple sclerosis, cognitive function, and quality of life. Brain and Behavior 2018; 8(2); 875.
Garg N., Smith T.W. An update on immunopathogenesis, diagnosis, and treatment
of multiple sclerosis. Brain and Behavior 2015; 5(9); 362.
Dymecka J., Bidzan M., Rautszko R. Skala Niesprawności Neurologicznej Szpitala Guy jako istotne narzędzie do oceny objawów występujących u osób z SM. Niepełnosprawność – zagadnienia, problemy, rozwiązania 2017; 1(22); 85-106.
Füvesi J. The Expanded Disability Status Scale scoring in patients with multiple sclerosis. Clinical Neuroscience 2019; 72 ; 9-10.
Kilenova S., Lublin F. D. Clinical Course of Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine 2018; 4; 8-9.
Hunter S. F. Overview and diagnosis of multiple sclerosis. Am J Manag Care 2016; 22; 141-150.
Goodin D.S. The epidemiology of multiple sclerosis: insights to disease pathogenesis. Clinical Neurology 2014; 11; 231- 263.
Tafti D., Ehsan M., Xixis K. L. Multiple Sclerosis. In StatPearls Treasure Island 2022; 9.
Oh J., Vidal-Jordana A., Montalban X. Multiple sclerosis: clinical aspects. Current Opinion in Neurology 2018; 31(6); 752-759.
Meyer-Moock S., Feng Y.S., Maeurer M. Systematic literaturę review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurology 2014; 25; 14-58.
Beer S., Khan F., Kesselring J. Rehabilitation interventions in multiple sclerosis:
an overview. Journal of Neurology 2012; 259; 1994-2008.
Amatya B., Khan F., Galea M. Rehabilitation for people with multiple sclerosis:
an overview of Cochrane Reviews. The Cochrane database of systematic review 2019;14;1(1).
Halabchi F., Alizadeh Z., Sahraian M.A. Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations. BMC Neurology 2017;17(1); 185.
Razazian N., Kazeminia M., Moayedi H. The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurology 2020; 20(1); 93.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Agata Grochala, Krzysztof Zdziarski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 431
Number of citations: 0
